North America commands the largest installed base, driven by ASC conversions and favorable CMS reimbursement, while Asia-Pacific emerges as the fastest-expanding region with a >8% CAGR, underpinned by China’s hospital-building boom and India’s surging procedural volumes. Competitive intensity is intensifying as incumbents pivot from hardware to subscription-style analytics suites; meanwhile, the EU MDR and FDA’s 510(k) tightening are redrawing regulatory timelines. On the supply side, semiconductor shortages have eased but FPGA and CMOS sensor lead times remain volatile, forcing OEMs to dual-source and regionalize manufacturing. Collectively, these dynamics underpin a market characterized by technology-driven premiumization, regulatory complexity and accelerating replacement demand.